| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
113,490 |
81,069 |
$8.07M |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
8,465 |
8,300 |
$662K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
6,590 |
6,571 |
$556K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,902 |
4,899 |
$414K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
23,351 |
21,852 |
$294K |
| 99460 |
|
3,679 |
3,678 |
$260K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
3,644 |
3,639 |
$220K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,232 |
2,231 |
$214K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,680 |
1,661 |
$171K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
1,628 |
1,626 |
$150K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
6,918 |
6,914 |
$116K |
| 90677 |
|
763 |
763 |
$109K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
9,175 |
8,952 |
$109K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
2,529 |
2,347 |
$63K |
| 99462 |
|
1,933 |
1,644 |
$61K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,118 |
2,709 |
$59K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
590 |
590 |
$57K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
9,866 |
9,805 |
$57K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,362 |
3,093 |
$47K |
| 90670 |
|
2,915 |
2,904 |
$39K |
| 99442 |
|
527 |
518 |
$39K |
| 99051 |
|
6,989 |
6,299 |
$37K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
362 |
362 |
$36K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,673 |
1,997 |
$32K |
| 97802 |
|
7,525 |
7,518 |
$32K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
231 |
231 |
$31K |
| 17250 |
|
173 |
173 |
$12K |
| 90686 |
|
3,680 |
3,652 |
$11K |
| 90619 |
|
432 |
432 |
$7K |
| G0008 |
Administration of influenza virus vaccine |
646 |
645 |
$6K |
| 90716 |
|
1,987 |
1,983 |
$5K |
| 90707 |
|
1,974 |
1,969 |
$5K |
| 90651 |
|
705 |
703 |
$4K |
| 90744 |
|
2,357 |
2,352 |
$3K |
| 36415 |
Collection of venous blood by venipuncture |
7,038 |
6,952 |
$3K |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
1,628 |
1,583 |
$3K |
| 0072A |
|
74 |
73 |
$3K |
| A4206 |
Syringe with needle, sterile, 1 cc or less, each |
2,619 |
2,480 |
$3K |
| G0444 |
Annual depression screening, 5 to 15 minutes |
475 |
475 |
$3K |
| 99381 |
|
25 |
25 |
$2K |
| 0071A |
|
58 |
58 |
$2K |
| 0012A |
|
45 |
45 |
$2K |
| 90658 |
|
226 |
225 |
$2K |
| 69210 |
|
32 |
32 |
$2K |
| 0011A |
|
45 |
45 |
$1K |
| A7016 |
Dome and mouthpiece, used with small volume ultrasonic nebulizer |
1,458 |
1,411 |
$1K |
| 90698 |
|
3,177 |
3,155 |
$965.45 |
| 90633 |
|
1,428 |
1,423 |
$923.70 |
| 90680 |
|
2,235 |
2,228 |
$874.00 |
| 90656 |
|
230 |
230 |
$863.46 |
| 90715 |
|
388 |
388 |
$851.84 |
| 90700 |
|
1,641 |
1,638 |
$793.31 |
| 90657 |
|
102 |
102 |
$684.15 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
88 |
88 |
$567.61 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
77 |
77 |
$552.67 |
| 0002A |
|
13 |
13 |
$498.72 |
| 0001A |
|
13 |
13 |
$483.76 |
| 90734 |
|
249 |
249 |
$473.76 |
| 91307 |
|
145 |
141 |
$431.71 |
| 90713 |
|
773 |
769 |
$426.47 |
| 0031A |
|
13 |
13 |
$411.82 |
| 90648 |
|
243 |
243 |
$223.41 |
| 91300 |
|
125 |
115 |
$171.55 |
| G0009 |
Administration of pneumococcal vaccine |
12 |
12 |
$165.17 |
| J7614 |
Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 0.5 mg |
1,596 |
1,553 |
$150.35 |
| G0010 |
Administration of hepatitis b vaccine |
15 |
14 |
$132.51 |
| 96127 |
|
74 |
74 |
$27.12 |
| 3008F |
|
12 |
12 |
$0.01 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
6,709 |
6,704 |
$0.00 |
| 91301 |
|
47 |
47 |
$0.00 |
| 90710 |
|
15 |
15 |
$0.00 |
| 99072 |
|
1,116 |
839 |
$0.00 |